Unleashing the Power of Proteomics
About Ignite Proteomics
For Physicians
Our 32-analyte assay will assist the treating physician in a data-driven process for treatment decision support and enable new predictive protein biomarker-based selection
Learn More
For Investors
Company overview, the announced NYSE business combination, our investment thesis, and investor resources, written for a financial audience.
Learn More
For BioPharma Partners
Pathway-based assessment of the activated proteome using Reverse Phase Protein Array (RPPA) and laser capture microdissection (LCM) to support therapeutic development in oncology and immuno-oncology from discovery through clinical trials.
Learn MoreWatch: Ignite Proteomics in 3 Minutes
3-minute explainer video
In preparationContact Us
Physicians - For questions about the test and how to order it in your office, please contact mike.vallone@igniteproteomics.com
BioPharma Partners - For questions about our technology and collaboration, please contact kayla.sparks@igniteproteomics.com
Investors - For all investor-related questions about Ignite Proteomics, please contact investors@igniteproteomics.com